# Effect of a Probiotic Supplement on Gut Microbiota and Glycemic Control in Patients With Type 1 Diabetes (PRODIAB)

> **NCT07062224** · NA · NOT_YET_RECRUITING · sponsor: **Universidad Católica San Antonio de Murcia** · enrollment: 80 (estimated)

## Conditions studied

- Diabete Type 1

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic/Prebiotic Supplement
- **DIETARY_SUPPLEMENT:** Placebo Gel

## Key facts

- **NCT ID:** NCT07062224
- **Lead sponsor:** Universidad Católica San Antonio de Murcia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2025-11
- **Final completion:** 2025-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07062224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07062224, "Effect of a Probiotic Supplement on Gut Microbiota and Glycemic Control in Patients With Type 1 Diabetes (PRODIAB)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07062224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*